Recently, there has been an increased focus on improving the quality of drug supply data at EU level, underpinned by a number of policy developments, notably the Council of the European Union's conclusions of 15 November 2013 regarding supply and supply reduction within the implementation of the...

In 2014, the EMCDDA took the decision to carry out a limited follow-up study of the EMCDDA Paper Drug squads: units specialised in drug law enforcement in Europe (EMCDDA, 2013), with the aim of monitoring possible changes and trends in drug supply reduction resulting from law enforcement...

Drug markets can be seen from the perspective of supply and demand. Market-related indicators, therefore, particularly administrative data, such as seizures, price, purity and drug-related offences, are used in most countries for assessment of the drug situation and policy evaluation. However,...

The problem drug use (PDU) indicator is one of the five EMCDDA key epidemiological indicators, addressing key aspects of the prevalence and harms of drug use at the European level. National experts from the PDU network provide prevalence estimates of high-risk drug use by substance and the...

Comparable and reliable data about the number and characteristics of people entering specialised drug treatment in EU Member States is essential for understanding the European drug problem. The EMCDDA has been collecting data on drug treatment entrants through the Treatment demand indicator...

Injecting drugs is a key risk factor for contracting viral and other infections. Blood-borne infections acquired through the sharing of injecting equipment are among the most serious health harms of drug use. The drug-related infectious disease (DRID) indicator collects data on the extent of...

National drug policies address the health and social costs of drug use and the policing and security issues raised by drug production and trafficking. The strategic approach taken by governments needs to respond to problems linked to both established illicit drugs, such as heroin, cocaine and...

This report is prepared in the framework of the EMCDDAIPA5 project 'Further preparation of the IPA beneficiaries for their participation with the European Monitoring Centre for Drugs and Drug Addiction' funded by the European Commission. It provides the top-level overview of the drug phenomenon...

This report is prepared in the framework of the EMCDDA-IPA5 project 'Further preparation of the IPA beneficiaries for their participation with the European Monitoring Centre for Drugs and Drug Addiction' funded by the European Commission. It provides a top-level overview of the drug phenomenon...